N/A N=40 Randomized Health Services Research

Telemedicine Strategy With Home Treatment Save Resources

Type 2 Diabetes Mellitus

Bottom Line

View on ClinicalTrials.gov: NCT02214017 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2018

Primary outcome: Primary: Glycemia — 7.1; 7.6 percent of glycosylated hemoglobin

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: A videotelephone, TandBerg E20, (Device); Behavioral motivation (Behavioral)
Age: Adult, Older Adult · 40+ yrs
Sex: All
Sponsor: Kolding Sygehus
Primary completion: Jul 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Glycemia	7.1; 7.6	—
SECONDARY Lipids	3.9; 3.6	—

Summary

Progress in technology has made telemedicine-based solutions with video consultations available in the management and treatment of chronic diseases like diabetes, heart failure and lung insufficiency at home. However, no direct comparisons on health outcomes of telemedicine using video consultations versus usual outpatient treatment are available. We wanted to implement a model of telemedicine and to evaluate health indicators in type 2 diabetes patients treated by video consultations or the standard outpatient treatment

Eligibility Criteria

Inclusion Criteria

The participants had to live at home, be able to communicate by videotelephone, had no psychiatric disorders, an age between 40 and 85 years and be able to administer medication. -

Exclusion Criteria

Exclusion criteria were type 1 diabetes, speech disabilities, non-Danish speakers or with severe chronic disease like renal failure (GFR<30 ml/min), liver insufficiency or in cancer treatment.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02214017). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.